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Chemoembolisation Using Drug Eluting Beads: Magic Bullets Targeted by 
Arterial Guidance 
HEAYSMAN CL1, LEWIS AL1, HALL, B1. 
1Biocompatibles UK Ltd, Chapman House, Farnham Business Park, Weydon Lane, 
Farnham, Surrey, GU9 8QL UK;  
Transarterial chemoembolisation (TACE) is used in the treatment of 
hypervascularised tumours such as hepatocellular carcinoma (HCC) and involves 
delivering a drug into the hepatic artery followed by occlusion of the artery with an 
embolisation agent to starve the tumour of oxygen and nutrients. Although 
randomised studies have demonstrated a survival benefit for TACE (Llovet et al. 
2002), the procedure varies vastly in clinical practise leading to inconsistent 
outcomes. Drug eluting beads (DEB) have been developed from sulfonate-modified 
polyvinyl alcohol hydrogel microspheres. These devices are capable of targeting 
tumours with drugs by flow-directed delivery down the feeding arteries and 
subsequent embolisation of the tumour capillary bed. The DEB affect intra-arterial 
delivery of chemotherapeutic agents over a sustained period in a controlled manner; 
deliver a high concentration of drug local to the site of the tumour; reduce the 
systemic exposure to free drug; occlude the tumour arterial blood supply. DEB have 
been well characterised in vitro with respect to loading and elution of drugs such as 
doxorubicin and the effects on the physical attributes of the beads related to 
catheter delivery (Lewis et al. 2006a; Gonzalez et al. 2007; Lewis et al. 2007). 
These drug-device combinations have been evaluated in a number of pre-clinical 
models that demonstrate the concept of high local delivery of the drug combined 
with lower systemic exposure (Hong et al. 2006; Lewis et al. 2006b). These data are 
supported by encouraging preliminary phase I/II clinical results in the treatment of 
HCC (Varela et al. 2007). This presentation will provide an overview the bench-to-
bedside development of these drug-device combinations for the treatment of liver 
cancer. 
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Background. Traditionally the preparations of streptokinase (SK) are used in 
clinical medicine for dissolution of thrombi, fibrin deposits. 
In 1987-1991, we described pronounced superoxide dismutase-like activity of SK in 
chemical systems of superoxide radical generation, the inhibition of  plasminogen-
activating ability of SK by scavengers of superoxide radical (nitrotetrazolium blue, 
adrenaline), nucleotides (АТР, сАМР and NAD at rather high concentration: ≥ 0.01 
М).   
In 1993 we proposed the SK-containing composition for the treatment of patients 
with long-nonhealing wounds (a patent of the Russian Federation). Its local 
application in several surgical clinics of Minsk has yielded good results – the healing 
of such wounds was achieved in all cases. 
In 1991, instillation of the SK solutions in eyes was used for treatment of guinea 
pigs with experimental herpetic keratoconjunctivitis (a patent of the USSR). 
Since 1999, on the transplanted cells cultures of rat glioma С6 and human 
neuroblastoma IMR-32 the mitogenic effect of SK (10–11–10–7 М), its stimulation of 
neuroblastoma cells as well as changes of intracellular contents of DNA, RNA and 
protein have been demonstrated. The exposition of rat pheochromocytoma PC12 
cell culture with 5 ۟·(10–10–10–6 М) only during 20 min was accompanied by significant 
changes of the level of АТР- and Са2 +-activated intracellular proteolysis. 
On organotypical and dissociated cultures of rat neocortex, sensory (spinal) and 
vegetative ganglia  (on the nutrient mediums with deficiency of blood serum 
proteins), the neurotrophic effect of SK was established. It manifested itself by 
maintenance of vital activity of cells at deprivation of blood serum proteins, cold 
stress, damaging effect of anionic form of АТР, and stimulation of proliferation of 
glia, Schwann cells and other cells. 
The cleavage of bovine fibrinogen in a thin layer of agar gel by washed cells of 
Pseudomonas aeruginosa hospital strain (grown up on plain agar) was inhibited by 
20-100 % after SK additions to the cells on.  
Conclusions. The scope of the results creates real preconditions for expansion of 
the medical application sphere of SK preparations, first of all, for stimulation of 
tissues’ regeneration and, perhaps, for treatment of neurological pathology. 
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